Allianz Asset Management GmbH
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1535323
MUNICH, 2M
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,176,768
+$164,928 QoQ
Shares Held
9,600
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#173
of 343 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allianz Asset Management GmbH holds $690,566,615 across 64 Biotechnology names. PTGX ranks #26 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
327,683 | $204,323,456 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
564,696 | $136,074,794 | |
| 3 | MRNA |
Moderna, Inc.
|
989,897 | $69,322,486 | |
| 4 | EXEL |
Exelixis, Inc.
|
853,093 | $46,416,787 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
179,500 | $23,825,035 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
400,036 | $22,890,059 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
1,127,337 | $19,615,663 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
706,664 | $17,878,599 |
All Filings in PTGX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,176,768 | 9,600 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,011,840 | 9,600 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,135,420 | 13,000 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,307,209 | 19,678 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $1,232,521 | 22,300 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $309,504 | 6,400 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $424,600 | 11,000 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $868,500 | 19,300 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $384,615 | 11,100 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $321,123 | 11,100 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $494,500 | 21,500 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $234,565 | 21,500 | Shares | Defined | 2023-02-13 | |
| 2022-06-30 | $1,297,833 | 164,075 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,143,141 | 132,734 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,609,920 | 134,793 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $871,310 | 49,171 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $3,332,788 | 74,260 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,923,334 | 74,260 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,497,081 | 74,260 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,451,783 | 74,260 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,338,451 | 75,790 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $720,811 | 102,098 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||